ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 1802

$693K Total Retail Price of All Prescriptions

Rank: 28 out of 1802

636 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 636 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 636 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,755 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 606 527 1 1
LISINOPRIL 514 413 2 3
OMEPRAZOLE 492 425 3 4
HYDROCODONE-ACETAMINOPHEN 414 266 S3 4 10
LEVOTHYROXINE SODIUM 411 316 5 2
HYDROCHLOROTHIAZIDE 405 328 6 8
AMLODIPINE BESYLATE 402 365 7 6
WARFARIN SODIUM 381 328 8 7
FUROSEMIDE 358 334 9 5
ATENOLOL 342 290 10 12
METOPROLOL TARTRATE 301 269 11 9
METOPROLOL SUCCINATE 287 244 12 13
ENALAPRIL MALEATE 255 208 13 40
POTASSIUM CHLORIDE 213 190 14 15
METFORMIN HCL 172 140 15 11
CITALOPRAM HBR 148 97 16 17
TRAMADOL HCL 147 79 17 22
ATORVASTATIN CALCIUM 139 126 18 14
NAMENDA 123 123 19 34
COMBIVENT 119 88 20 108
GABAPENTIN 109 68 21 16
PRAVASTATIN SODIUM 101 63 22 19
TRAZODONE HCL 101 88 22 39
SERTRALINE HCL 100 71 24 20
TAMSULOSIN HCL 97 92 25 28
ZOLPIDEM TARTRATE 96 53 26 27
DIOVAN 92 86 27 57
LANTUS 87 72 28 47
ISOSORBIDE MONONITRATE ER 86 69 29 66
FLUOXETINE HCL 85 38 30 35
LOVASTATIN 84 81 31 25
LOSARTAN POTASSIUM 79 62 32 18
ADVAIR DISKUS 78 74 33 32
ISOSORBIDE DINITRATE 77 63 34 211
VENLAFAXINE HCL ER 77 62 34 73
JANUVIA 76 48 36 76
PAROXETINE HCL 75 66 37 60
ALENDRONATE SODIUM 74 60 38 21
FLUTICASONE PROPIONATE 72 58 39 37
GLIPIZIDE ER 72 58 39 82
RANITIDINE HCL 70 54 41 30
MIRTAZAPINE 69 39 42 38
METFORMIN HCL ER 68 54 43 46
CRESTOR 67 48 44 31
ALLOPURINOL 66 52 45 24
NOVOLOG 65 54 46 100
PREDNISONE 63 55 47 33
DONEPEZIL HCL 62 60 48 26
CYCLOBENZAPRINE HCL 61 25 R 49 69
OXYCODONE HCL 56 25 S2 50 41
AGGRENOX 54 54 51 200
GEMFIBROZIL 53 37 52 83
GLIMEPIRIDE 53 45 52 42
NITROSTAT 52 38 54 287
GLIPIZIDE XL 51 50 55 98
CARVEDILOL 51 46 55 36
SINGULAIR 50 19 57 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.